Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 7 ... complexes with gH, is a conserved herpesvirus protein that is essential for Epstein-Barr virus (EBV) entry into host cells. The gH/gL complex has a conserved role in entry among ... Fatigue Syndrome, Drugs, EBV, Epstein-Barr Virus, Herpes, Herpesvirus, Medical Device, Pharmaceuticals, Proteomics, Therapy, Treatment, Virology, Northwestern University. This ...
2009 OCT 12 ... Inc. ("ELN" and the "Company") (TSX.V ELN) is pleased to announce that Mr. Harry Barr has been appointed Chairman and Acting CEO of the Company. Mr. Barr's ... Keywords: El Nino Ventures Inc., Democratic, Government, Politics, Copper, Drugs, Pharmaceuticals, Therapy, Treatment This article was prepared by Biotech Business Week ...
2009 OCT 12 ... that had previously been part of a strategic collaboration between Hospira and PLIVA/Barr, the latter two companies now owned by Teva Pharmaceutical Industries Ltd. ... Licensing Agreements, Pegfilgrastim, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Therapy, Treatment, Hospira Inc. This ...
2009 SEP 21 ... certain proprietary products targeting pandemic viral infections including Epstein Barr Virus (EBV), human and avian influenza, Hepatitis B and C ! and other ... Immunodeficiency Virus, Immunization, Infectious Disease, Influenza Virus, Pandemics, Pharmaceuticals, Therapies, Therapy, Treatment, Viral Research, Virology. This article was ... Lakewood-Amedex Inc., (L-A), the anti-infectives biopharmaceutical company developing a unique portfolio of ...
2009 AUG 31 ... Managed Health Care Associates, Inc. (MHA) is pleased to announce that Gloria Barr, Esq., has joined MHA as Vice President & General Counsel. In this newly created role, ... in-house clients. Keywords: Biotechnology Business, Biotechnology Company, Pharmaceuticals, Managed Health Care Associates Inc. This article was prepared by Biotech ...
2009 NOV 3 ... Roche Laboratories and Boehringer Ingelheim, and more specialized operations, such as Barr Labs, Alcon and Cord Blood Registry. During his years at DraftFCB, the ... as OTC and medical devices. Keywords: Behavioral Science, Oral Science, Pharmaceuticals, StrikeForce Communications. This article was prepared by Drug Law Weekly ...
2009 OCT 27 ... of early life adversity consumed more alcohol in a limited-access paradigm," wrote C.S. Barr and colleagues, National Institutes of Health. The researchers concluded: ... Proteins, DNA, DNA Research, DNA Protein Interaction, Medical Device, Corticotropin, Pharmaceuticals, Drugs, Therapy, Treatment, Pathology, National Institutes of Health. This ...
2009 OCT 12 ... mean time of graft function of 137.0 +/- 68.00 months. All of the patients were Epstein-Barr-negative. Four received a combination of Rituximab and cyclophosphamide, doxorubicin, ... Monoclonal Antibodies, Monoclonal Antibody, Nephrology, Oncology, Organ Transplant, Pharmaceuticals, Renal Allograft, Renal Transplant, Therapy, Transplantation, Treatment. ... of the journal Transplantation Proceedings can be contacted at: Elsevier Science Inc., 360 Park Avenue South, New York, NY 10010-1710, USA. Keywords: Spain, ...
2009 SEP 28 ... We speculate that the caps may provide a secondary site of calcium entry," wrote V.A. Barr and colleagues, Center for Cancer Research. The researchers concluded: ... Sciences, Cancer, Oncology, Immunology, Cancer Research, Pharmacological, Physiology, Pharmaceuticals. This article was prepared by Clinical Oncology Week editors from staff and ... publisher of the journal Immunological Reviews can be contacted at: Blackwell Publishing Inc., 350 Main St., Malden, MA 02148, USA. Keywords: United States, Bethesda, ...
2009 SEP 21 ... Topoisomerase I (Topo I) and Topo II inhibitors can selectively inhibit Epstein-Barr virus (EBV) lytic cycle DNA replication," scientists in the United States report. ... Epstein-Barr Virus, Etoposide, Gene Therapy, Herpes, Herpesvirus, Medical Device, Pharmaceuticals, Proteins, Proteomics, Topoisomerase, Topoisomerase I, Treatment, Viral Inhibition, ...
2009 SEP 14 ... 4.7% at 15 years. It has been reported in patients with or without concomitant Epstein-Barr virus infection." "Therapy ranges from a reduction of immunosuppression ... Disorder, Medical Device, Monoclonal Antibodies, Oncology, Organ Transplant, Pharmaceuticals, Pharmacology, Therapies, Transplantation, Treatment, Virology, University of Texas. ...
2009 OCT 5 ... (range 4-30+). Cumulative myelosuppression and neuropathy was observed," wrote P.M. Barr and colleagues, University Hospital, Department of Medicine. The ... Cell Lymphoma, Medical Device, Monoclonal Antibodies, Non-Hodgkin Lymphoma, Oncology, Pharmaceuticals, Proteomics, Therapy, Treatment. This article was prepared by Biotech ... of the British Journal of Haematology can be contacted at: Blackwell Publishing Inc., 350 Main St., Malden, MA 02148, USA. Keywords: United States, Non-Hodgkin ...
2009 NOV 1 ... to Sandoz are involved in the settlement agreement. Impax PharmaceuticalsInc. and Barr Laboratories Inc. remain the only authorized generic supplier of ADDERALL XR. ...
2009 AUG 24 ... identify, consummate and integrate acquisitions, including the integration of BarrPharmaceuticals, Inc., the potential exposure to product liability claims to the extent ...
2009 NOV 9 ... announced that its subsidiary Watson Laboratories, Inc. has reached a settlement with Barr Laboratories, Inc. on outstanding patent litigation related to Watson's Oxytrol=AE ... Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced that its ...
